A. Muñoz and J. Xu, MODELS FOR THE INCUBATION OF AIDS AND VARIATIONS ACCORDING TO AGE AND PERIOD, Statistics in Medicine, vol.15, issue.22, pp.2459-73, 1996.
DOI : 10.1002/(SICI)1097-0258(19961130)15:22<2459::AID-SIM464>3.0.CO;2-Q

P. Tarwater, J. Mellors, and M. Gore, Methods to Assess Population Effectiveness of Therapies in Human Immunodeficiency Virus Incident and Prevalent Cohorts, American Journal of Epidemiology, vol.154, issue.7, pp.675-81, 2001.
DOI : 10.1093/aje/154.7.675

A. Babiker, J. Darbyshire, P. Pezzotti, K. Porter, G. Rezza et al., Steering Committee: Valerie Beral, Roel Coutinho, Appendix Analysis and Writing Committee

A. Babiker, S. Walker, J. Darbyshire, F. Tyrer-aquitaine-cohort, and F. , Edinburgh Hospital cohort, UK: Ray Brettle; Madrid cohort, Spain: Julia Del Amo Jorge del Romero; Amsterdam Cohort Study among drug users, the Netherlands: Maria Prins, Roel A Coutinho; Amsterdam Cohort Study on homosexual men, the Netherlands: Birgit van Benthem, Roel A Coutinho Court PedersenHoyos; Oslo and Ulleval Hospital cohorts, Daniela De Angelis. virus infection. HIV Outpatient Study Investigators, pp.853-60, 1998.

R. Detels, A. Muñoz, and G. Mcfarlane, Effectiveness of Potent Antiretroviral Therapy on Time to AIDS and Death in Men With Known HIV Infection Duration, Multicentre AIDS Cohort Study Investigators, pp.1497-503, 1998.
DOI : 10.1001/jama.280.17.1497

M. Dorrucci, M. Balducci, and P. Pezzotti, Temporal Changes in the Rate of Progression to Death Among Italians With Known Date of HIV Seroconversion: Estimates of the Population Effect of Treatment, Journal of Acquired Immune Deficiency Syndromes, vol.22, issue.1, pp.65-70, 1999.
DOI : 10.1097/00042560-199909010-00008

R. Moore and R. Chaisson, Natural history of HIV infection in the_era of combination antiretroviral therapy, AIDS, vol.13, issue.14, pp.1933-1975, 1999.
DOI : 10.1097/00002030-199910010-00017

B. Ledergerber, A. Telenti, M. Egger, . For-the-swiss, . Hiv-cohort et al., Risk of HIV related Kaposi's sarcoma and non-Hodgkin's lymphoma with potent antiretroviral therapy: prospective cohort study, BMJ, vol.319, issue.7201, pp.23-24, 1999.
DOI : 10.1136/bmj.319.7201.23

D. Forrest, E. Seminari, and R. Hogg, The Incidence and Spectrum of AIDS???Defining Illnesses in Persons Treated with Antiretroviral Drugs, Clinical Infectious Diseases, vol.27, issue.6, pp.1379-85, 1998.
DOI : 10.1086/515030

R. Detels, P. Tarwater, and J. Phair, Effectiveness of potent antiretroviral therapies on the incidence of opportunistic therapies before and after AIDS diagnosis 15 CASCADE Collaboration. Changes in uptake of antiretroviral therapy and survival in persons with known duration of HIV infection in Europe, AIDS HIV Medicine, vol.151, pp.347-55224, 2000.

. Anon, Expanded European AIDS case definition, Lancet, vol.341, p.441, 1993.

D. Cox, Regression Models and Life-Tables, J R Statist Soc, vol.34, pp.187-220, 1972.
DOI : 10.1007/978-1-4612-4380-9_37

J. Kalbfleisch and R. Prentice, The Statistical Analysis of Failure Time Data, 1990.
DOI : 10.1002/9781118032985

P. Andersen, O. Borgan, R. Gill, and N. Keiding, Statistical Models based on Counting Processes, 1993.
DOI : 10.1007/978-1-4612-4348-9

J. Fine and R. Gray, A Proportional Hazards Model for the Subdistribution of a Competing Risk, Journal of the American Statistical Association, vol.69, issue.446, pp.496-509, 1999.
DOI : 10.2307/2530374

D. Cox, Partial likelihood, Biometrika, vol.62, issue.2, pp.269-76, 1975.
DOI : 10.1093/biomet/62.2.269

L. Wei, D. Lin, and L. Weissfeld, Regression Analysis of Multivariate Incomplete Failure Time Data by Modeling Marginal Distributions, Journal of the American Statistical Association, vol.4, issue.408, pp.1065-73, 1989.
DOI : 10.1002/sim.4780070115

P. Huber, The behaviour of maximum likelihood estimates under non-standard conditions, Proceedings of the Fifth Berkeley Symposium on Mathematical Statistics and Probability, pp.221-254, 1967.

C. Clayton and M. Hills, Statistical Models in Epidemiology, 1993.

. Statacorp, Stata Statistical Software: Release 7.0. College Station, TX: Stata Corporation, 2001.

A. Muñoz, S. Gange, and L. Jacobsen, Distinguishing efficacy, individual effectiveness and population effectiveness of therapies, AIDS, vol.6, pp.754-56, 2000.

. Anon, Recommendations for prophylaxis against Pneumocystis carinii pneumonia for adults and adolescents infected with human immunodeficiency virus, MMWR, vol.41, issue.4, pp.1-11, 1992.

O. Kirk, C. Pedersen, C. Lepri, and A. , Non-Hodgkin lymphoma in HIV-infected patients in the era of highly active antiretroviral therapy, Blood, vol.98, issue.12, pp.3406-3418, 2001.
DOI : 10.1182/blood.V98.12.3406